| Results 161 - 170 of 210 |
| 16/08/06 | SGS to acquire 7 layers UK Ltd and to become one of the largest European GSM testing companies | ||||||||||||||||||||||||||
| 18/07/06 | SGS 2006 Half Year Results | ||||||||||||||||||||||||||
| 30/06/06 | SGS SA to Divest its Australian Washroom Services Business | ||||||||||||||||||||||||||
| 21/06/06 | Life Science | SGS launches new quality control testing services for biopharmaceuticals at AAPS Biotechnology Conference | |||||||||||||||||||||||||
| 19/05/06 | Governments and Institutions | Conformity Assessment for exports to the Kingdom of Saudi Arabia The New conformity Assessment Program for Goods to be exported to the Kingdom of Saudi Arabia is coordinated by the Ministry of Commerce and Industry. | |||||||||||||||||||||||||
| 23/02/06 | SGS Speed up the Localization in China On the 14th of February SGS’s first proprietary office in the Asia Pacific region was opened in Guangzhou, China. | ||||||||||||||||||||||||||
| 20/02/06 | SGS announces changes to its Board of Directors | ||||||||||||||||||||||||||
| 09/02/06 | SGS acquires Northview Biosciences Inc. and becomes largest network of GMP-quality control testing laboratories worldwide SGS announces today the acquisition of Northview Biosciences Inc, Northbrook Illinois. | ||||||||||||||||||||||||||
| 17/01/06 | SGS 2005 Year End Results With revenue growth of 14.7% (13.2% constant currency basis) to CHF 3.3 billion, SGS achieved a fourth consecutive year of improved performance delivering a 27.7% increase in operating income to CHF 502 million at an operating margin of 15.2 %. | ||||||||||||||||||||||||||
| 05/01/06 | SGS becomes European leader in early clinical research with the acquisition of aster.cephac SGS announces today the acquisition of aster.cephac headquartered in Paris, France, a full service provider of early clinical pharmacology trials (Phase I/IIa trials) and bioanalytical drug development services. aster.cephac serves the pharmaceutical and biotechnology industries globally. | ||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||